All Type of News
SK Chemical to be splitted from SK Groups.
The SK group transformation into SK Holdings, a stock holding company system put 7 SK subsidiaries such as SK Telecom and SK energy chemical put under the umbrella of SK Holdings Inc but other 7 affiliates including S...
Joint IRB to review multicenter clinical studies
The Korea Food and Drug Administration said on May 1 that multicenter clinical trials will be reviewed by a joint Institutional Review Board (IRB) in a bid to ensure more speedy clinical tests for home-grown drugs.
...
Pharmacy markets expecting a marketing for "Month of Family" in May.
May, "month of family" has come, May 5 is the day of children, May 8 is the day of parents, May 15 is the day of teachers and May 19 is the day of the coming-of-age. The retail pharmacy markets hope that many celebrat...
Yungjin offers apology for Coenzyme Q10 patent infringement
Yungjin Pharm admitted that it has violated Coenzyme Q10-related patent Daewoong Chemical and Daewoong Pharm has owned and carried its apology in trade papers.
Last year, Daewoong filed a suit against Yungjin over ...
Korea drafts plans for FTA-damaged pharmaceutical sector
Following the clinching of a free trade agreement with the United States, the government has drawn up a number of schemes to reap optimal results from the pact.
The outline of the plans, submitted to the National ...
Health insurance to evaluate cost-effectiveness on existing medicines
The Health Insurance Review Agency (HIRA) unveiled its plan on April 30 to determine a list of drugs covered by the insurance according to price and efficacy.
To this end, the agency will classify a total of 16,529...
KFDA to implement major revamp in review systems.
The KFDA announced a significant revamp plan for the drug registration system by establishing 104 civil service reform programs to satisfy the civil needs and substantially to improve the service quality including the...
Government develops hospital incentive system
The government will ask the national health insurance to pay higher doctors fees to hospitals providing high-quality medical services. In contrast, hospitals offering poor-quality medical services are expected to rece...
Choongwae favors "stock-holding company" system.
Following Green Cross and Daewoong in the pharmaceutical industry, Choongwae has shown a favorable attitude for the new company governing system called "stock-holding company" system.
Choongwae plans to establish C...
Yearly 160 BW of pharmaceutical business losses under FTA.
It is estimated for the local pharmaceutical industry to face about 90.4 to 168.8 billion won of annual pharmaceutical sales losses for 10 years under the KORUS FTA according to "Analysis of KORUS FTA economic effects...
